MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, NVNO made $383K in revenue. -$4,539K in net income. Net profit margin of -1185.12%.

Income Overview

Revenue
$383K
Net Income
-$4,539K
Net Profit Margin
-1185.12%
EPS
-$0.23
Unit: Thousand (K) dollars
Revenue Breakdown
    • Realized gains from sales of tra...
    • Interest income, net

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
Research and development expenses
2,585
Selling, general and administrative expenses
2,298
Loss from operations
-4,883
Realized gains from sales of trading securities
208
Unrealized gain (loss) from trading securities
-39
Interest income, net
175
Total other income
344
Net loss
-4,539
Basic
20,155,000
Diluted
20,155,000
Net loss per basic common share
-0.23
Net loss per diluted common share
-0.23
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income, net$175K Realized gains from salesof trading...$208K Net loss-$4,539K Total other income$344K Unrealized gain (loss) fromtrading securities-$39K Loss from operations-$4,883K Selling, general andadministrative expenses$2,298K Research and developmentexpenses$2,585K

enVVeno Medical Corp (NVNO)

enVVeno Medical Corp (NVNO)